Account
Havas Media wins ClubMyCab’s integrated media AOR
MUMBAI: Havas Media has won the integrated media mandate of ClubMyCab in a multi-agency pitch. The account will be handled from the agency’s New Delhi office.
ClubMyCab is a ride sharing app that makes ride sharing safe and fun. The biggest obstacle to ride sharing taking off in a big way in India is that people don’t feel safe sharing a cab or car with strangers. ClubMyCab believes that sharing works best with people you trust – friends, colleagues and neighbours – not with strangers.
ClubMyCab founder-CEO Pratul Chopra said, “Ride sharing is still a nascent concept in India and requires building customer awareness towards the benefits. We are therefore partnering with Havas Media to take this message to our customers. We believe Havas Media’s vast experience and established infrastructure in customer communication design and delivery will be of immense value to ClubMyCab.”
Havas Media Group-India and South Asia CEO Anita Nayyar added, “ClubMyCab is an innovative concept and very necessary in the daily lives of Indians. Comfort, affordability and above all safety are the key drivers in travel today and ClubMyCab offers these. More so travelling in a more social environment helps beat the traffic grind and also allows for a happier disposition and hence higher productivity. We look forward to partner with the team as they scale in India.”
“ClubMyCab offers an interesting and timely proposition also ensuring people are in their comfort-safety zone as they commute. Apps and the digital frontier are witnessing exciting growth in India. The Havas Media unique digital offering is perfectly suited to connect and engage with this audience, encouraging evolving customer behaviour,” said Havas Media Group-India managing director Mohit Joshi.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
